Francesca Di Gennaro
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial.
Journal: Future oncology (London, England)
Published: August 27, 2026
First-line lenvatinib and sorafenib in RR-DTC from a shared real-life context.
Journal: Endocrine-related cancer
Published: August 20, 2025
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 29, 2024
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 27, 2023
Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis.
Journal: Journal of clinical medicine
Published: November 11, 2022
A comparison of simplified protocols of personalized dosimetry in NEN patients treated by radioligand therapy (RLT) with [177Lu]Lu-DOTATATE to favor its use in clinical practice.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 10, 2022
Analysis of Pros and Cons in Using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer.
Journal: Molecules (Basel, Switzerland)
Published: May 23, 2022
Oligometastatic prostate cancer treatment.
Journal: Future oncology (London, England)
Published: July 23, 2021
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm.
Journal: Critical reviews in oncology/hematology
Published: July 08, 2020
Diagnostic imaging of parotid gland oncocytoma: a pictorial review with emphasis on ultrasound assessment.
Journal: Journal of ultrasound
Published: May 18, 2020
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 27, 2018
Last Updated: 09/26/2026